|The DBH dbh (Catalog #MBS244779) is an Antibody produced from Sheep and is intended for research purposes only. The product is available for immediate purchase. The Sheep Polyclonal to Human DBH/Dopamine Beta Hydroxylase reacts with Human, Mouse, Primate and may cross-react with other species as described in the data sheet. MyBioSource\'s DBH/Dopamine Beta Hydroxylase can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC - Paraffin), Western Blot (WB).
IHC-P (1:100), WB (1:1000). Researchers should empirically determine the suitability of the DBH dbh for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The DBH dbh product has the following accession number(s) (GI #116534900) (NCBI Accession #NP_000778.3) (Uniprot Accession #P09172). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Sheep Polyclonal to Human DBH/Dopamine Beta Hydroxylase with the following immunoassay(s):
Immunohistochemistry (IHC) (Anti-DBH antibody IHC of human adrenal. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody dilution 1:100.)
Western Blot (WB) (Western blot of human adrenal medulla lysate showing specific immunolabeling of the ~75k DBH protein.)
Target Species: Human
Immunogen Description: Peptide from the C-terminal region of human dopamine R-hydroxylase (DBH), conjugated to keyhole limpet hemocyanin (KLH). Immunogen: DBH/Dopamine Beta Hydroxylase antibody was raised against peptide from the C-terminal region of human dopamine R-hydroxylase (DBH), conjugated to keyhole limpet hemocyanin (KLH).
Antigen Modification: C-Terminus. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing DBH are readily searchable from our website. Different antibodies against the same target such as DBH may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Bipolar Disorder, Depressive Disorder, Hypertension, Hypotension, Mental Disorders, Movement Disorders, Nervous System Diseases, Neurotoxicity Syndromes, Parkinson Disease, Pheochromocytoma are some of the diseases may be linked to Sheep Polyclonal to Human DBH/Dopamine Beta Hydroxylase. The following patways have been known to be associated with this gene. DBH also interacts with the following gene(s): COMT, CYB561, DDC, MAOA, MAOB, NPY, PNMT. Adrenal Gland, Brain, Embryonic Tissue, Ganglia, Lymph Node, Mouth, Nerve, Testis tissues are correlated with this protein.